Main Article Content


Thalassemia is a hereditary form of anemia that affects the synthesis of hemoglobin. The management of therapy in patients with b-thalassemia major which patients should receive continuous blood transfusions and increased iron absorption from the digestive tract causes excess iron in the body. This will lead to an increase of free iron level that triggers Radical Oxygen Species (ROS). Increased level of ROS can initiate lipid peroxidation which used as an indicator of oxidative stress in cells and tissues and produce reactive carbonyl, mainly malondialdehyde (MDA). Thus, MDA measurement is widely used as an indicator of lipid peroxidation. On the other hand, the risk of oxidative damage can be reduced by antioxidant, one of them is Vitamin E that is a fat-soluble vitamin with high potential antioxidant. The objective of this study was to analyze the effect of the dl-a-tocopherol (Vitamin E) administration on decrease of MDA serum level on pediatric patients with b-thalassemia major. This was a longitudinal observational study design for one group without comparison was conducted to examine the use of vitamin E to decreased MDA serum level on children patients with b-thalassemia major. The inclusion criteria were patients who rely on blood transfusions, patients who received only one type of iron chelating agents during the study period, the clinical condition is stable, agrees, and has completed the informed consent. In the course of the study of 21 patients there were variations in patient compliance in taking vitamin E tablet dosage 200 IU once-daily for one month: only 11 out of 21 patients consumed 30 tablets of vitamin E 200 IU (total dose of 6000 IU) in the 1-month study, and only data from those 11 samples will be analysed further. MDA serum level was measured pre- and post-administration of vitamin E and patient's characteristics of subjects was obtained for additional information. Pre-administration of vitamin E, serum level of MDA was 1239.4 ± 502.55 ng/mL with a range of 216.95 to 2297.3 ng/mL, whereas in the group post administration of vitamin E, MDA serum level was 786.49 ± 704.88 ng/mL with a range of 6.5380 to 1958.6 ng/mL. In conclusion, there was no significant difference in MDA serum level in the group pre- and post- administration of vitamin E (p = 0.15).


-thalassemia major Vitamin E MDA antioxidant ROS lipid peroxidation

Article Details

How to Cite
Rismayanti, L., Yulistiani, Y., Andarsini, M. R., & Qibtiyah, M. (2017). ANALYSIS OF DL--TOCOPHEROL AS ANTIOXIDANT ON MALONDIALDEHYDE LEVEL IN PEDIATRIC PATIENTS WITH -THALASSEMIA MAJOR. Folia Medica Indonesiana, 53(1), 49–55.


  1. AlHakeim, H. K., Auda, F. M. & Ali, B. M., 2014. Lack of Correlation between Nonlabile Iron Parameters, Total Carbonyl, and Malondialdehyde in Major Thalassemia. Journal of Clinical Biochemis-try and Nutrition, Volume 55(3), p. 203–206.
  2. Arijanty, L. & Nasar, S. S., 2003. Masalah Nutrisi pada Thalassemia. Sari Pediatri, Volume 5, pp. 21-26.
  3. Ayala, A., Muñoz, M. F. & Argüelles, S., 2014. Lipid Peroxidation: Production, Metabolism, and Signal-ing Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative Medicine and Cellular Longevity, Volume 2014, pp. 1-31.
  4. Badan Penelitian dan Pengembangan Kesehatan, 2007. Riset Kesehatan Dasar. Jakarta: Departemen Kesehatan Republik Indonesia.
  5. Bhagat, S. S. et al., 2012. A Study on the Biomarkers of Oxidative Stress: the Effects of Oral Therapeutic Supplementation on the Iron Concentration and the Product of Lipid Peroxidation in ï‚ Thalassemia Major. Journal of Clinical and Diagnostic Research, Volume 6, pp. 1144-1147.
  6. Bhagat, S. S. et al., 2013. Attenuation of Serum Ferritin and Iron Burden by Intake of Antioxidants in ï‚ Thalassemia Major. Indian Journal Physiology Pharmacology, Volume 57(2), p. 189–194.
  7. Das, N., Chowdhury, T. D., Chattopadhyay, A. & Datta, A. G., 2004. Attenuation of Oxidative Stress-Induced Changes in Thalassemic Erythrocytes by Vitamin E. Polish Journal Pharmacology, Volume 56, pp. 85-96.
  8. Dissayabutra, T., Tosukhowong, P. & Seksan, P., 2005. The Benefits of Vitamin C and Vitamin E in Children with ï¢-thalassemia with High Oxidative Stress. Journal of The Medical Association of Thailand, Volume 88(Suppl 4), pp. S317-21.
  9. Fang, Y.-Z., Yang, S. & Wu, G., 2002. Free Radicals, Antioxidants, and Nutrition. Nutrition, Volume 18, p. 872–879.
  10. Fitrianto, A., Tamam, M. & Widyastiti, N. S., 2014. Vitamin E Effect on Osmotic Fragility in B Thalassemia Major. Paediatrica Indonesiana, Volume 54, pp. 280-3.
  11. Fucharoen, S. & Weatherall, D. J., 2012. The Hemoglobin E Thalassemias. Cold Spring Harbor Perspectives in Medicine, Volume 2, p. a011734.
  12. Goswami, K., Ghosh, S., Bandyopadhyay, M. & Mukherjee, K., 2005. Iron Store and Free Radicals in Thalassemia. Indian Journal of Clinical Biochemistry, Volume 20(2), pp. 192-194.
  13. Gultom, F. & Adhiyanto, C., 2004. Efek Pemberian Antioksidan Tokoferol Alfa terhadap Membran Sel Darah Merah Talasemia. Indonesian Journal of Dentistry, Volume 11(2), pp. 71-72.
  14. Gunarsih, A., Amalia, P. & Boediman, I., 2012. Variables Associated with Malondialdehyde Level in Thalassemia Major Patients. Paediatrica Indonesiana, Volume 52(3), pp. 125-131.
  15. Mahjoub, S., Tamaddoni, A., Nikoo, M. Z. & Moghadamnia, A. A., 2007. The Effects of ï‚-Carotene and Vitamin E on Erythrocytes Lipid Peroxidation in ï‚-Thalassemia Patients. Journal of Research in Medical Sciences, Volume 12(6), pp. S317-S321.
  16. Rachmilewitz, E. A. & Giardina, P. J., 2011. How I Treat Thalassemia. Blood Journal, Volume 118, pp. 3479-3488.
  17. Rashidi, M. et al., 2011. Effects of Vitamin E and Zinc Supplementation on Antioxidants in ï‚ Thalassemia Major Patients. Iranian Journal of Pediatrics, Volume 21(1), pp. 8-14.
  18. Saud, A. M., 2012. Molecular and Biochemical Study on ï¢-thalassemia Patients in Iraq. Thesis.
  19. Tamam, M. et al., 2012. Hubungan antara Stres Oksidatif dengan Kadar Hemoglobin pada Penderita Thalassemia/Hbe. Jurnal Kedokteran Brawijaya, Volume 27(1), pp. 38-42.
  20. World Health Organization, 2013. Birth Defects In South-east Asia A Public Health Challenge. New Delhi: World Health Organization.

Most read articles by the same author(s)

1 2 > >>